Regeneron Pharmaceuticals (REGN) Share-based Compensation Growth (3y) (2012 - 2026)
Regeneron Pharmaceuticals (REGN) Share-based Compensation Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 4.80% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 10.78% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | 2.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.55% |
| Dec 31, 2025 | 2.43% |
| Sep 30, 2025 | 12.53% |
| Jun 30, 2025 | 16.35% |
| Mar 31, 2025 | 15.28% |
| Dec 31, 2024 | 17.34% |
| Sep 30, 2024 | 18.03% |
| Jun 30, 2024 | 15.33% |
| Mar 31, 2024 | 20.69% |
| Dec 31, 2023 | 25.54% |
| Sep 30, 2023 | 26.30% |
| Jun 30, 2023 | 24.97% |
| Mar 31, 2023 | 31.16% |
| Dec 31, 2022 | 20.23% |
| Sep 30, 2022 | 12.40% |
| Jun 30, 2022 | 14.74% |
| Mar 31, 2022 | 15.65% |
| Dec 31, 2021 | 14.14% |
| Sep 30, 2021 | 7.08% |
| Jun 30, 2021 | 10.86% |